I waited two years for a start-up grant and wrote ten project versions. Anna Vanluchene explains the Illuminating Flow concept, photocatalysis in flow reactors, and building an independent research team.

The TERAFIT project is developing next-generation magnetic materials—antiferromagnets and altermagnets—that could replace silicon chips and enable faster, energy-efficient IT technologies.

CEITEC scientists have experimentally shown for the first time that even weak halogen bonds between molecules share electrons, revealing a partly covalent nature.

A team at IOCB Prague revealed a novel phase where liquids flip rapidly between metal and nonmetal states. The theory, based on advanced modeling, was featured in Nature Communications.

Dr. Tomáš Pluskal has been accepted into the prestigious ‘Young Investigator Programme’ of the EMBO and has also secured the ERC grant.

Scientists from IOCB Prague have created compounds a million times more stable than those used to treat tumors or as contrast agents for magnetic resonance imaging.

An important step in countering antibiotic resistance has been made by researchers from IOCB Prague, the Institute of Microbiology and the Institute of Biotechnology of the CAS.

IOCB Prague opened its new branch in Boston, USA on October 18, 2024. The move puts the institute in proximity to scientific institutions, such as Harvard University, MIT, and Boston Medical Center.

Researchers from IOCB Prague are furthering the understanding of how medicines work and what it takes to develop their most effective variants.

Even heavily modified double helices of DNA are stable enough to be used for special applications.